Janus Henderson Group’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.3M	Sell	4,196,409 -1,154,044	-22%	-$15.8M	0.03%	380
2025 Q4	$73.9M	Buy	5,350,453 +649,341	+14%	+$15.3M	0.03%	344
2025 Q3	$115M	Buy	4,701,112 +240,780	+5%	+$5.86M	0.05%	257
2025 Q2	$103M	Sell	4,460,332 -137,760	-3%	-$3.63M	0.05%	257
2025 Q1	$134M	Buy	4,598,092 +1,035,690	+29%	+$39M	0.07%	227
2024 Q4	$191M	Buy	3,562,402 +1,038,996	+41%	+$55M	0.1%	198
2024 Q3	$115M	Buy	2,523,406 +721,563	+40%	+$31.4M	0.06%	257
2024 Q2	$75.4M	Sell	1,801,843 -163,703	-8%	-$7.69M	0.04%	302
2024 Q1	$74M	Buy	1,965,546 +34,069	+2%	+$742K	0.04%	314
2023 Q4	$20.7M	Sell	1,931,477 -135,991	-7%	-$1.18M	0.01%	541
2023 Q3	$20.8M	Sell	2,067,468 -41,870	-2%	-$483K	0.01%	521
2023 Q2	$25M	Buy	2,109,338 +240,262	+13%	+$3.21M	0.02%	519
2023 Q1	$22.6M	Buy	1,869,076 +31,285	+2%	+$521K	0.01%	550
2022 Q4	$24.2M	Sell	1,837,791 -2,082,297	-53%	-$30.5M	0.02%	525
2022 Q3	$53.1M	Buy	3,920,088 +1,792,291	+84%	+$23.9M	0.02%	502
2022 Q2	$26M	Sell	2,127,797 -211,349	-9%	-$2.5M	0.02%	516
2022 Q1	$33.5M	Sell	2,339,146 -61,747	-3%	-$1.01M	0.02%	619
2021 Q4	$46.6M	Sell	2,400,893 -15,511	-0.6%	-$325K	0.02%	566
2021 Q3	$51.4M	Sell	2,416,404 -251,803	-9%	-$7.24M	0.02%	546
2021 Q2	$64.5M	Buy	+2,668,207	New	+$59.4M	0.03%	502